Measuring TNF-a Levels in Liver and Tumor Tissue of Cancer Patients
Author Information
Author(s): PJK Kuppen, LE Jonges, CJH van de Velde, AL Vahrmeijer, RAEM Tollenaar, IHM Borel Rinkes, AMM Eggermont
Primary Institution: Leiden University Hospital
Hypothesis
Isolated liver perfusion with TNF-a and melphalan will increase TNF-a levels in liver and tumor tissues of colorectal cancer patients.
Conclusion
The study found that isolated liver perfusion significantly increased TNF-a levels in liver tissue, but not preferentially in tumor tissue.
Supporting Evidence
- TNF-a levels in liver tissue increased significantly after perfusion in all evaluable patients.
- One out of five patients showed a significant increase in TNF-a levels in tumor tissue after treatment.
- The TNF-a levels in liver tissue were much higher than those in tumor tissue after treatment.
Takeaway
Doctors wanted to see how a special treatment affects a substance called TNF-a in the liver and tumors of cancer patients, and they found that the treatment worked well in the liver but not as much in the tumors.
Methodology
The study used an adapted ELISA method to measure TNF-a levels in liver and tumor biopsies taken before and after isolated liver perfusion.
Limitations
The study had a small sample size and some tumor samples were too small to measure TNF-a levels.
Participant Demographics
Patients with colorectal metastases confined to the liver, including both males and females aged 50 to 65.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website